CDER Data Standards Program

Each year, CDER receives more than 300,000 submissions, amounting to millions of pieces of data. CDER reviews the data to bring lifesaving new drugs to market while protecting public health. The data can arrive in a wide variety of formats and even on paper,...

Expanded Access to Experimental Biologics

Clinical trials are studies of drugs and biologics that are still in development and have not yet been approved by the FDA. Many patients enroll in clinical trials to gain access to investigational therapies and contribute to finding out how well an investigational...

GARDASIL 9

STN:   125508Proper Name: Human Papillomavirus 9-valent Vaccine, RecombinantTradename: GARDASIL 9Manufacturer: Merck Sharp & Dohme LLCIndications: Indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: Cervical,...

Industry (Biologics)

Image CBER’s Policies, Procedures, and Review ResourcesThis webpage provides important resources related to the regulatory framework of products regulated by CBER, including policies, procedures, and review resources.CBER reviews applications for new products, new...